ESKILD A PETERSEN, MD
Osteopathic Medicine at Campbell Ave, Tucson, AZ

License number

Arizona 8983

Personal information

See more information about ESKILD A PETERSEN at radaris.com

Name

Address

Phone

Eskild Petersen

San Simon, AZ

(520) 558-0016

Eskild A Petersen

3160 Via Celeste, Tucson, AZ 85718

(520) 299-4223

Eskild Petersen

1501 Campbell Ave, Tucson, AZ 85724

(520) 626-6887

Organization information

See more information about ESKILD A PETERSEN at bizstanding.com

Eskild Petersen MD

1501 N Campbell Ave, Tucson, AZ 85724

Industry:

Internist

Phone:

(520) 626-6887 (Phone)

Eskild Antoni Petersen

Professional information

See more information about ESKILD A PETERSEN at trustoria.com

Dr. Eskild A Petersen, San Simon AZ - MD (Doctor of Medicine)

Specialties:

Infectious Disease Medicine

Address:

1282 W Crk Rd, San Simon 85632

Certifications:

Infectious Disease, 1980, Internal Medicine, 1977

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

1282 W Crk Rd, San Simon 85632
The University of Arizona Medical Center
1501 North Campbell Ave, Tucson 85724

Education:

Medical School
University of Copenhagen / College of Medicine
Tucson Med Center
University Med Center

Eskild A Petersen, Tucson AZ

Specialties:

Infectious Disease Specialist

Address:

1501 N Campbell Ave, Tucson, AZ 85724

Education:

University of Copenhagen, Faculty of Health Sciences - Doctor of Medicine

Board certifications:

American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)

Monoclonal Antibodies Specific For Hiv And The Hybridomas For Production Thereof

US Patent:

5783670, Jul 21, 1998

Filed:

Jun 7, 1995

Appl. No.:

8/487529

Inventors:

Yasuhiko Masuho - Tokyo, JP
Toru Sugano - Tokyo, JP
Yoh-ichi Matsumoto - Tokyo, JP
Takashi Kawamura - Tokyo, JP
Evan Hersh - Tucson AZ
Eskild Petersen - Tucson AZ
Douglas Lake - Tucson AZ

Assignee:

The University of Arizona, Department of Internal Medicine, Section of
Hematology and Oncology - Tucson AZ
Teijin Limited - Osaka

International Classification:

C07K 1610, A61K 3942

US Classification:

53038815

Abstract:

Human monoclonal antibodies which belong to the IgGl subclass and are specific for HIV are described. The monoclonal antibodies have potential for use in the diagnosis, prevention and therapy of HIV infection.

Monoclonal Antibodies Specific For Hiv And The Hybridomas For Production Thereof

US Patent:

5695927, Dec 9, 1997

Filed:

Jul 1, 1994

Appl. No.:

8/270214

Inventors:

Yasuhiko Masuho - Tokyo, JP
Toru Sugano - Tokyo, JP
Yoh-ichi Matsumoto - Kichijohjikita-machi, JP
Takashi Kawamura - Tokyo, JP
Evan Hersh - Tucson AZ
Eskild Petersen - Tucson AZ
Douglas Lake - Tucson AZ

Assignee:

The University of Arizona, Department of Internal Medicine, Section of
Hematology and Oncology - Tucson AZ
Teijin Limited - Osaka

International Classification:

C12Q 170

US Classification:

435 5

Abstract:

Human monoclonal antibodies which belong to the IgG1 subclass and are specific for HIV are described. The monoclonal antibodies have potential for use in the diagnosis, prevention and therapy of HIV infection.

Monoclonal Antibodies Specific For Hiv And Hybridomas For Their Production

US Patent:

5445960, Aug 29, 1995

Filed:

May 24, 1993

Appl. No.:

8/065522

Inventors:

Yasuhiko Masuho - Tokyo, JP
Toru Sugano - Tokyo, JP
Yoh-Ichi Matsumoto - Tokyo, JP
Evan M. Hersh - Tucson AZ
Eskild A. Petersen - Tucson AZ
Douglas Lake - Tucson AZ
Takashi Kawamura - Tokyo, JP

Assignee:

The Arizona Board of Regents on behalf of the University of Arizona - Tucson AZ
Teijin Limited - Osaka

International Classification:

C12N 524, C07K 1528

US Classification:

43524027

Abstract:

Human IgG1 monoclonal antibodies are produced by hybridoma ATCC HB10074 and bind to gp120 of HIV.

Antibiotic Formulation And Use For Bacterial Infections

US Patent:

6221388, Apr 24, 2001

Filed:

Sep 28, 1999

Appl. No.:

9/407798

Inventors:

Evan M. Hersch - Tucson AZ
Eskild A. Petersen - Tucson AZ
Richard T. Proffitt - Arcadia CA
Kevin R. Bracken - Sunland CA
Su-Ming Chiang - Canoga Park CA

Assignee:

Gilead Sciences, Inc. - Foster City CA

International Classification:

A61K 9127, A61K 9133

US Classification:

424450

Abstract:

A liposomal aminoglycoside formulation comprising a neutral lipid, a negatively charged lipids and a sterol. The formulation contains unilamellar vesicles having an average size below 100 nm. A process of making liposomes containing an aminoglycoside is also provided. A method is also provided for the treatment of drug susceptible and drug resistant bacteria.

Antibiotic Formulation And Use For Drug Resistant Infections

US Patent:

5756120, May 26, 1998

Filed:

Jun 6, 1995

Appl. No.:

8/468497

Inventors:

Evan M. Hersch - Tucson AZ
Eskild A. Petersen - Tucson AZ
Richard T. Proffitt - Arcadia CA
Kevin R. Bracken - Sunland CA
Su-Ming Chiang - Canoga Park CA

Assignee:

NeXstar Pharmaceuticals, Inc. - Boulder CO

International Classification:

A61K 9127, A61K 9133

US Classification:

424450

Abstract:

A liposomal aminoglycoside formulation comprising a neutral lipid, a negatively charged lipids and a sterol. The formulation contains unilamellar vesicles having an average size below 100 nm. A process of making liposomes containing an aminoglycoside is provided where the hydration temperature is significantly below the transition temperature of the formulation. A method for the treatment of drug susceptible and drug resistant bacteria.

Antibiotic Formulation And Use For Drug Resistant Infections

US Patent:

5759571, Jun 2, 1998

Filed:

Jun 23, 1993

Appl. No.:

8/084218

Inventors:

Evan M. Hersch - Tucson AZ
Eskild A. Petersen - Tucson AZ
Richard T. Proffitt - Arcadia CA
Kevin R. Bracken - Sunland CA
Su-Ming Chiang - Canoga park CA

Assignee:

NeXstar Pharmaceuticals, Inc. - Boulder CO

International Classification:

A61K 9127, A61K 9133

US Classification:

424450

Abstract:

A liposomal aminoglycoside formulation comprising a neutral lipid, a negatively charged lipids and a sterol. The formulation contains unilamellar vesicles having an average size below 100 nm. A process of making liposomes containing an aminoglycoside is provided where the hydration temperature is significantly below the transition temperature of the formulation. A method for the treatment of drug susceptible and drug resistant bacteria.

Antibiotic Formulation And Use For Bacterial Infections

US Patent:

5958449, Sep 28, 1999

Filed:

May 21, 1998

Appl. No.:

9/082633

Inventors:

Evan M. Hersch - Tucson AZ
Eskild A. Petersen - Tucson AZ
Richard T. Proffitt - Arcadia CA
Kevin R. Bracken - Sunland CA
Su-Ming Chiang - Canoga Park CA

Assignee:

NeXstar Pharmaceuticals, Inc. - Boulder CO

International Classification:

A61K 9127, A61K 9133

US Classification:

424450

Abstract:

A liposomal aminoglycoside formulation comprising a neutral lipid, a negatively charged lipid and a sterol. The formulation contains unilamellar vesicles having an average size below 100 nm. A process of making liposomes containing an aminoglycoside is provided. A method is also provide for the treatment of drug susceptible and drug resistant bacteria.